Advertisement

Циклоплатин 200

Основна информация

  • Търговско наименование:
  • Циклоплатин 200 (Cycloplatin 200)
  • Предлага се от:
  • Pliva Lachema a.s.
  • дозиране:
  • 200 mg x 5
  • Лекарствена форма:
  • прах за инфузионен разтвор
  • Композиция:
  • прах за инфузионен разтвор 200 mg x 5
  • Използвай за:
  • Хората
  • Вид на лекарството:
  • алопатични наркотици
Advertisement

Документи

Локализация

  • Предлага се в:
  • Циклоплатин 200 (Cycloplatin 200)
    България
  • Език:
  • български

Друга информация

Състояние

  • Източник:
  • Изпълнителна агенция по лекарствата - Bulgarian Drug Agency - Bulgaria
  • Последна актуализация:
  • 09-08-2016

Листовка за пациента


5-10-2017

Surflink Media and Surflink Media 2 (Models 200 and 210) - used with wireless hearing aids

Surflink Media and Surflink Media 2 (Models 200 and 210) - used with wireless hearing aids

Recall for product correction - may cause interference with mobile towers

Therapeutic Goods Administration - Australia

20-9-2017

Nature Supplement Inc. Issues Voluntary Florida Recall of Vegetable Vigra Due to Undeclared Sildenafil

Nature Supplement Inc. Issues Voluntary Florida Recall of Vegetable Vigra Due to Undeclared Sildenafil

Natures Supplement, Inc. is voluntarily recalling 260 bottles of VEGETABLE VIGRA, 200 mg capsules to the consumer level. FDA analysis found this product to be tainted with Sidenafil. Sildenafil is an FDA approved drug for the treatment of erectile dysfunction, the presence of Sildenafil in the Vegetable Vigra product renders it an unapproved drug for which safety and efficacy has not been established, therefore subject to recall.

FDA - U.S. Food and Drug Administration

16-6-2017

Hospira Issues a Voluntary Nationwide Recall For 8.4% Sodium Bicarbonate Injection, USP, Neut <sup>tm</sup> (Sodium Bicarbonate 4% Additive Solution), QUELICIN <sup>tm</sup> (Succinylcholine Chloride Injection, USP) and Potassium Phosphates Injection, USP

Hospira Issues a Voluntary Nationwide Recall For 8.4% Sodium Bicarbonate Injection, USP, Neut <sup>tm</sup> (Sodium Bicarbonate 4% Additive Solution), QUELICIN <sup>tm</sup> (Succinylcholine Chloride Injection, USP) and Potassium Phosphates Injection, USP

Hospira, Inc., a Pfizer company, is voluntarily recalling 42 lots of 8.4% Sodium Bicarbonate Injection, USP, 50 mL vials, 5 lots of NeutTM (Sodium Bicarbonate 4% additive solution) 5 mL vials, 5 lots of QUELICINTM (Succinylcholine Chloride Injection, USP) 200 mg/10 mL vials and 7 lots of Potassium Phosphates Injection, USP, 45 mM vials to the hospital/retail level due to microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of micr...

FDA - U.S. Food and Drug Administration

26-5-2017

Astrazeneca Initiates Voluntary Nationwide Recall of One Lot of Brilinta 90 mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle From That Lot

Astrazeneca Initiates Voluntary Nationwide Recall of One Lot of Brilinta 90 mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle From That Lot

AstraZeneca today announced that the Company is notifying physicians and consumers that it is voluntarily recalling one lot of professional (physician) sample bottles containing eight tablets of BRILINTA (ticagrelor) 90mg tablets as a precautionary measure. This voluntary recall follows a report that a professional sample bottle containing eight tablets of BRILINTA 90mg also contained another medicine called ZURAMPIC (lesinurad) 200 mg tablets which is also manufactured by AstraZeneca.

FDA - U.S. Food and Drug Administration

14-12-2017

ANTI-AGING FOUNDATION SPF 15 SHADE 200 (Octinoxate) Emulsion [La Prairie, Inc.]

ANTI-AGING FOUNDATION SPF 15 SHADE 200 (Octinoxate) Emulsion [La Prairie, Inc.]

Updated Date: Dec 14, 2017 EST

US - DailyMed

6-12-2017

CARBOPLATIN Injection, Solution [Hospira, Inc.]

CARBOPLATIN Injection, Solution [Hospira, Inc.]

Updated Date: Dec 6, 2017 EST

US - DailyMed

27-11-2017

Carboplatin vs. Cytoxan

Carboplatin vs. Cytoxan

Carboplatin and Cytoxan (cyclophosphamide) are anti-cancer medications used to treat ovarian cancer.

US - RxList

21-11-2017

MOOREBRAND IBUPROFEN (I Buprofen 200 Mg) Tablet, Film Coated [Moore Medical LLC]

MOOREBRAND IBUPROFEN (I Buprofen 200 Mg) Tablet, Film Coated [Moore Medical LLC]

Updated Date: Nov 21, 2017 EST

US - DailyMed

16-11-2017

SOUND BODY IBUPROFEN (Ibuprofen 200 Mg) Capsule, Liquid Filled [Allegiant Health]

SOUND BODY IBUPROFEN (Ibuprofen 200 Mg) Capsule, Liquid Filled [Allegiant Health]

Updated Date: Nov 16, 2017 EST

US - DailyMed

30-10-2017

MUCUS RELIEF (Guaifenesin 200 Mg) Tablet [Richmond Pharmaceuticals, Inc.]

MUCUS RELIEF (Guaifenesin 200 Mg) Tablet [Richmond Pharmaceuticals, Inc.]

Updated Date: Oct 30, 2017 EST

US - DailyMed

20-9-2017

CARBOPLATIN Injection [Accord Healthcare, Inc.]

CARBOPLATIN Injection [Accord Healthcare, Inc.]

Updated Date: Sep 20, 2017 EST

US - DailyMed

14-8-2017

Carboplatin

Carboplatin

Carboplatin is an anti-cancer medication indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. One established combination regimen consists of carboplatin injection and cyclophosphamide. Carboplatin injection is also indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin.

US - RxList

18-7-2017

IBUPROFEN 200 (Ibuprofen) Tablet, Coated [Walgreen Company]

IBUPROFEN 200 (Ibuprofen) Tablet, Coated [Walgreen Company]

Updated Date: Jul 18, 2017 EST

US - DailyMed

19-6-2017

CARBOPLATIN Injection, Solution [Meitheal Pharmaceuticals Inc.]

CARBOPLATIN Injection, Solution [Meitheal Pharmaceuticals Inc.]

Updated Date: Jun 19, 2017 EST

US - DailyMed

9-6-2017

TERRAMYCIN 200 GRANULAR (Oxytetracycline) Powder [Phibro Animal Health]

TERRAMYCIN 200 GRANULAR (Oxytetracycline) Powder [Phibro Animal Health]

Updated Date: Jun 9, 2017 EST

US - DailyMed

9-6-2017

TERRAMYCIN 200 (Oxytetracycline) Powder [Phibro Animal Health]

TERRAMYCIN 200 (Oxytetracycline) Powder [Phibro Animal Health]

Updated Date: Jun 9, 2017 EST

US - DailyMed

26-5-2017

CELECOXIB 200 MG (Celecoxib) Capsule [Preferred Pharmaceuticals Inc.]

CELECOXIB 200 MG (Celecoxib) Capsule [Preferred Pharmaceuticals Inc.]

Updated Date: May 26, 2017 EST

US - DailyMed

23-3-2017

CELECOXIB 200 MG (Celecoxib) Capsule

CELECOXIB 200 MG (Celecoxib) Capsule

Updated Date: Mar 23, 2017 EST

US - DailyMed

28-2-2017

CELECOXIB 200 MG (Celecoxib) Capsule [Aidarex Pharmaceuticals LLC]

CELECOXIB 200 MG (Celecoxib) Capsule [Aidarex Pharmaceuticals LLC]

Updated Date: Feb 28, 2017 EST

US - DailyMed

21-2-2017

CARBOPLATIN Injection, Solution [Gland Pharma Limited]

CARBOPLATIN Injection, Solution [Gland Pharma Limited]

Updated Date: Feb 21, 2017 EST

US - DailyMed

6-2-2017

CARBOPLATIN Injection [Sun Pharma Global FZE]

CARBOPLATIN Injection [Sun Pharma Global FZE]

Updated Date: Feb 6, 2017 EST

US - DailyMed

18-1-2017

ISOVUE-M 200 (Iopamidol) Injection, Solution [General Injectables Vaccines, Inc.]

ISOVUE-M 200 (Iopamidol) Injection, Solution [General Injectables Vaccines, Inc.]

Updated Date: Jan 18, 2017 EST

US - DailyMed

27-12-2016

PENNOX 200 HI-FLO (Oxytetracycline) Powder [Pharmgate Animal Health]

PENNOX 200 HI-FLO (Oxytetracycline) Powder [Pharmgate Animal Health]

Updated Date: Dec 27, 2016 EST

US - DailyMed

22-12-2016

Scientific guideline:  Draft elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil film-coated tablets 150 mg/150 mg/200 mg/ 245 mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil film-coated tablets 150 mg/150 mg/200 mg/ 245 mg product-specific bioequivalence guidance, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil.

Europe - EMA - European Medicines Agency

22-12-2016

Scientific guideline:  Draft emtricitabine/rilpivirine/tenofovir disoproxil, film-coated tablets, 200 mg/25 mg/245 mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft emtricitabine/rilpivirine/tenofovir disoproxil, film-coated tablets, 200 mg/25 mg/245 mg product-specific bioequivalence guidance, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of emtricitabine, rilpivirine, tenofovir and disoproxil.

Europe - EMA - European Medicines Agency

22-12-2016

Scientific guideline:  Draft Crizotinib hard capsules 200 mg and 250 mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft Crizotinib hard capsules 200 mg and 250 mg product-specific bioequivalence guidance, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of Crizotinib

Europe - EMA - European Medicines Agency

21-12-2016

CARBOPLATIN Injection, Solution [Fresenius Kabi USA, LLC]

CARBOPLATIN Injection, Solution [Fresenius Kabi USA, LLC]

Updated Date: Dec 21, 2016 EST

US - DailyMed

Advertisement